Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Epizyme Total Assets 2012-2020 | EPZM

Epizyme total assets from 2012 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Epizyme Annual Total Assets
(Millions of US $)
2019 $425
2018 $276
2017 $289
2016 $252
2015 $218
2014 $199
2013 $163
2012 $104
2011 $37
Epizyme Quarterly Total Assets
(Millions of US $)
2020-03-31 $452
2019-12-31 $425
2019-09-30 $334
2019-06-30 $371
2019-03-31 $413
2018-12-31 $276
2018-09-30 $203
2018-06-30 $239
2018-03-31 $260
2017-12-31 $289
2017-09-30 $321
2017-06-30 $205
2017-03-31 $224
2016-12-31 $252
2016-09-30 $279
2016-06-30 $301
2016-03-31 $323
2015-12-31 $218
2015-09-30 $238
2015-06-30 $245
2015-03-31 $253
2014-12-31 $199
2014-09-30 $221
2014-06-30 $238
2014-03-31 $251
2013-12-31 $163
2013-09-30 $147
2013-06-30 $162
2013-03-31 $0
2012-12-31 $0
2012-09-30 $0
2012-06-30 $0
2011-12-31 $37
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.762B $0.024B
Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.003B 14.31
Gilead Sciences (GILD) United States $93.325B 12.10
CSL (CSLLY) Australia $90.047B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.822B 49.38
Regeneron Pharmaceuticals (REGN) United States $66.482B 25.63
Illumina (ILMN) United States $52.673B 54.13
Biogen (BIIB) United States $49.381B 8.45
Seattle Genetics (SGEN) United States $26.839B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.124B 10.79
Moderna (MRNA) United States $22.233B 0.00
Incyte (INCY) United States $21.483B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
BioMarin Pharmaceutical (BMRN) United States $20.111B 182.31
Genmab (GMAB) Denmark $19.375B 15.96
Genmab (GNMSF) Denmark $17.902B 53.15
Alnylam Pharmaceuticals (ALNY) United States $15.759B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Exact Sciences (EXAS) United States $13.378B 0.00
BeiGene (BGNE) Cayman Islands $13.074B 0.00
Galapagos (GLPG) Belgium $12.943B 38.33
Sarepta Therapeutics (SRPT) United States $11.623B 0.00
BioNTech SE (BNTX) Germany $11.576B 0.00
QIAGEN (QGEN) Netherlands $10.039B 29.19
Bio-Techne Corp (TECH) United States $9.916B 65.51
ARGENX SE-ADR (ARGX) Netherlands $9.857B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.314B 22.92
Guardant Health (GH) United States $8.029B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.310B 0.00
Immunomedics (IMMU) United States $7.271B 0.00
Exelixis (EXEL) United States $7.105B 24.91
Ascendis Pharma (ASND) Denmark $7.006B 0.00
Repligen (RGEN) United States $6.651B 116.65
Adaptive Biotechnologies (ADPT) United States $5.032B 0.00
Acceleron Pharma (XLRN) United States $5.027B 0.00
MyoKardia (MYOK) United States $4.820B 0.00
Emergent Biosolutions (EBS) United States $4.527B 29.67
Reata Pharmaceuticals (RETA) United States $4.501B 0.00
China Biologic Products (CBPO) China $4.327B 24.06
Ultragenyx Pharmaceutical (RARE) United States $4.325B 0.00
Mirati Therapeutics (MRTX) United States $4.273B 0.00
MorphoSys AG (MOR) Germany $4.265B 33.08
Zai Lab (ZLAB) China $4.250B 0.00
Global Blood Therapeutics (GBT) United States $4.073B 0.00
Blueprint Medicines (BPMC) United States $4.039B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.963B 86.60
Vir Biotechnology (VIR) United States $3.940B 0.00
Bluebird Bio (BLUE) United States $3.623B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.489B 0.00
Arena Pharmaceuticals (ARNA) United States $3.453B 0.00
Amicus Therapeutics (FOLD) United States $3.311B 0.00
Halozyme Therapeutics (HALO) United States $3.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.172B 0.00
Denali Therapeutics (DNLI) United States $3.044B 0.00
NeoGenomics (NEO) United States $2.871B 209.69
Viela Bio (VIE) United States $2.802B 0.00
UniQure (QURE) Netherlands $2.782B 0.00
Alkermes (ALKS) Ireland $2.648B 52.13
Insmed (INSM) United States $2.614B 0.00
Novavax (NVAX) United States $2.565B 0.00
Amarin (AMRN) Ireland $2.560B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.526B 0.00
Alector (ALEC) United States $2.415B 0.00
Fate Therapeutics (FATE) United States $2.399B 0.00
Principia Biopharma (PRNB) United States $2.070B 0.00
Inovio Pharmaceuticals (INO) United States $1.965B 0.00
Eidos Therapeutics (EIDX) United States $1.909B 0.00
Ligand Pharmaceuticals (LGND) United States $1.895B 73.78
Zymeworks (ZYME) Canada $1.750B 0.00
Adverum Biotechnologies (ADVM) United States $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.623B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.547B 0.00
Mesoblast (MESO) Australia $1.520B 0.00
Twist Bioscience (TWST) United States $1.519B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.516B 0.00
Editas Medicine (EDIT) United States $1.510B 0.00
Akcea Therapeutics (AKCA) United States $1.503B 0.00
PHARMA MAR SA (PHMMF) Spain $1.494B 0.00
I-Mab (IMAB) China $1.472B 0.00
Beam Therapeutics (BEAM) United States $1.448B 0.00
Zealand Pharma (ZEAL) Denmark $1.438B 0.00
Arcus Biosciences (RCUS) United States $1.437B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
REGENXBIO (RGNX) United States $1.397B 0.00
NGM Biopharmaceuticals (NGM) United States $1.390B 0.00
Intra-Cellular Therapies (ITCI) United States $1.378B 0.00
Coherus BioSciences (CHRS) United States $1.337B 9.34
Arvinas (ARVN) United States $1.314B 0.00
Cytokineticsorporated (CYTK) United States $1.225B 0.00
Revance Therapeutics (RVNC) United States $1.223B 0.00
Mersana Therapeutics (MRSN) United States $1.191B 0.00
Compugen (CGEN) Israel $1.171B 0.00
Myriad Genetics (MYGN) United States $1.156B 59.62
Intellia Therapeutics (NTLA) United States $1.147B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.969B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.942B 0.00
Athenex (ATNX) United States $0.929B 0.00
Pharming Group (PHGUF) Netherlands $0.895B 0.00
Sorrento Therapeutics (SRNE) United States $0.868B 0.00
Cue Biopharma (CUE) United States $0.815B 0.00
Heska (HSKA) United States $0.811B 0.00
Cellectis S.A (CLLS) France $0.753B 0.00
Cara Therapeutics (CARA) United States $0.752B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.747B 0.00
Kala Pharmaceuticals (KALA) United States $0.746B 0.00
NextCure (NXTC) United States $0.740B 0.00
Codexis (CDXS) United States $0.733B 0.00
Morphic Holding (MORF) United States $0.731B 0.00
NantKwest (NK) United States $0.729B 0.00
Retrophin (RTRX) United States $0.722B 0.00
Alcobra (ARCT) United States $0.718B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.709B 0.00
Kadmon Holdings (KDMN) United States $0.690B 0.00
Vericel (VCEL) United States $0.660B 122.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.638B 0.00
Dynavax Technologies (DVAX) United States $0.632B 0.00
Bellus Health (BLU) Canada $0.630B 0.00
Agenus (AGEN) United States $0.629B 0.00
Castle Biosciences (CSTL) United States $0.626B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.625B 5.36
Syndax Pharmaceuticals (SNDX) United States $0.590B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
Frequency Therapeutics (FREQ) United States $0.573B 0.00
Athersys (ATHX) United States $0.572B 0.00
Intrexon (PGEN) United States $0.561B 0.00
UROGEN PHARMA (URGN) United States $0.547B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
MeiraGTx Holdings (MGTX) United States $0.523B 0.00
Cel-Sci (CVM) United States $0.522B 0.00
AnaptysBio (ANAB) United States $0.519B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.518B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.491B 0.00
Scholar Rock Holding (SRRK) United States $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.477B 25.10
Anika Therapeutics (ANIK) United States $0.471B 15.13
VBI Vaccines (VBIV) United States $0.466B 0.00
AC Immune SA (ACIU) Switzerland $0.455B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.433B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.428B 0.00
Protagonist Therapeutics (PTGX) United States $0.425B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.408B 0.00
Albireo Pharma (ALBO) United States $0.396B 0.00
Precision BioSciences (DTIL) United States $0.387B 0.00
MiMedx (MDXG) United States $0.387B 0.00
PDL BioPharma (PDLI) United States $0.372B 319.00
CytomX Therapeutics (CTMX) United States $0.370B 0.00
Seres Therapeutics (MCRB) United States $0.365B 0.00
Avid Bioservices (CDMO) United States $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 7.21
Selecta Biosciences (SELB) United States $0.348B 0.00
Kamada (KMDA) Israel $0.347B 14.44
WAVE Life Sciences (WVE) Singapore $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.324B 0.00
Geron (GERN) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.306B 0.00
Verastem (VSTM) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.295B 0.00
MannKind (MNKD) United States $0.294B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
ChromaDex (CDXC) United States $0.283B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.281B 0.00
Liquidia Technologies (LQDA) United States $0.274B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Affimed (AFMD) Germany $0.260B 0.00
Cellular Biomedicine (CBMG) United States $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.254B 0.00
Spero Therapeutics (SPRO) United States $0.254B 0.00
Pfenex (PFNX) United States $0.250B 0.00
Fortress Biotech (FBIO) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Prometic Life Sciences (LMNL) Canada $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 0.00
XOMA (XOMA) United States $0.239B 0.00
Northwest Biotherapeutics (NWBO) United States $0.238B 0.00
Exicure (XCUR) United States $0.237B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
POXEL SA FRANCE (PXXLF) France $0.217B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
IVERIC Bio (ISEE) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 3.05
ARAVIVE, INC (ARAV) United States $0.201B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Pluristem Therapeutics (PSTI) Israel $0.197B 0.00
TELA Bio (TELA) United States $0.194B 0.00
Kindred Biosciences (KIN) United States $0.194B 0.00
VTv Therapeutics (VTVT) United States $0.191B 0.00
IBio (IBIO) United States $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.182B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Five Prime Therapeutics (FPRX) United States $0.179B 0.00
Orgenesis (ORGS) United States $0.172B 0.00
Aptinyx (APTX) United States $0.169B 0.00
Celyad SA (CYAD) Belgium $0.165B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Cerecor (CERC) United States $0.155B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.145B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Arbutus Biopharma (ABUS) Canada $0.142B 0.00
Trevena (TRVN) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.140B 0.00
Enzo Biochem (ENZ) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
Cyclerion Therapeutics (CYCN) United States $0.131B 0.00
VolitionRX (VNRX) United States $0.131B 0.00
Palatin Technologies (PTN) United States $0.130B 3.33
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.124B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
AIT Therapeutics (XAIR) United States $0.116B 0.00
Checkpoint Therapeutics (CKPT) United States $0.116B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.106B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.103B 0.00
Windtree Therapeutics (WINT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
AquaBounty Technologies (AQB) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Celsion (CLSN) United States $0.079B 0.00
Synlogic (SYBX) United States $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
DiaMedica Therapeutics (DMAC) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
CollPlant Holdings (CLGN) Israel $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Signal Genetics (MGEN) United States $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
OvaScience (MLND) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.040B 0.00
TrovaGene (CRDF) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Evogene (EVGN) Israel $0.033B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Spherix (AIKI) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
VIVUS (VVUS) United States $0.019B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00